789 related articles for article (PubMed ID: 16480815)
21. Androgen formation and metabolism in the pulmonary epithelial cell line A549: expression of 17beta-hydroxysteroid dehydrogenase type 5 and 3alpha-hydroxysteroid dehydrogenase type 3.
Provost PR; Blomquist CH; Godin C; Huang XF; Flamand N; Luu-The V; Nadeau D; Tremblay Y
Endocrinology; 2000 Aug; 141(8):2786-94. PubMed ID: 10919264
[TBL] [Abstract][Full Text] [Related]
22. Structures of complexes of type 5 17β-hydroxysteroid dehydrogenase with structurally diverse inhibitors: insights into the conformational changes upon inhibitor binding.
Amano Y; Yamaguchi T; Niimi T; Sakashita H
Acta Crystallogr D Biol Crystallogr; 2015 Apr; 71(Pt 4):918-27. PubMed ID: 25849402
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of the cynomolgus monkey Macaca fascicularis steroidogenic enzymes belonging to the aldo-keto reductase family.
Liu H; Bellemare V; Labrie F; Luu-The V
J Steroid Biochem Mol Biol; 2007 Apr; 104(1-2):75-80. PubMed ID: 17257829
[TBL] [Abstract][Full Text] [Related]
24. Mapping of steroids binding to 17 beta-hydroxysteroid dehydrogenase type 1 using Monte Carlo energy minimization reveals alternative binding modes.
Blanchet J; Lin SX; Zhorov BS
Biochemistry; 2005 May; 44(19):7218-27. PubMed ID: 15882060
[TBL] [Abstract][Full Text] [Related]
25. Crystal structures of mouse 17alpha-hydroxysteroid dehydrogenase (apoenzyme and enzyme-NADP(H) binary complex): identification of molecular determinants responsible for the unique 17alpha-reductive activity of this enzyme.
Faucher F; Pereira de Jésus-Tran K; Cantin L; Luu-The V; Labrie F; Breton R
J Mol Biol; 2006 Dec; 364(4):747-63. PubMed ID: 17034817
[TBL] [Abstract][Full Text] [Related]
26. Pathways of adipose tissue androgen metabolism in women: depot differences and modulation by adipogenesis.
Blouin K; Nadeau M; Mailloux J; Daris M; Lebel S; Luu-The V; Tchernof A
Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E244-55. PubMed ID: 18984855
[TBL] [Abstract][Full Text] [Related]
27. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.
Rizner TL; Lin HK; Peehl DM; Steckelbroeck S; Bauman DR; Penning TM
Endocrinology; 2003 Jul; 144(7):2922-32. PubMed ID: 12810547
[TBL] [Abstract][Full Text] [Related]
28. 17beta-Hydroxysteroid dehydrogenase type 9 and other short-chain dehydrogenases/reductases that catalyze retinoid, 17beta- and 3alpha-hydroxysteroid metabolism.
Napoli JL
Mol Cell Endocrinol; 2001 Jan; 171(1-2):103-9. PubMed ID: 11165018
[TBL] [Abstract][Full Text] [Related]
29. Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer.
Smuc T; Rizner TL
Mol Cell Endocrinol; 2009 Mar; 301(1-2):74-82. PubMed ID: 18930784
[TBL] [Abstract][Full Text] [Related]
30. Structure and function of 3 alpha-hydroxysteroid dehydrogenase.
Penning TM; Bennett MJ; Smith-Hoog S; Schlegel BP; Jez JM; Lewis M
Steroids; 1997 Jan; 62(1):101-11. PubMed ID: 9029723
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase.
Dufort I; Rheault P; Huang XF; Soucy P; Luu-The V
Endocrinology; 1999 Feb; 140(2):568-74. PubMed ID: 9927279
[TBL] [Abstract][Full Text] [Related]
32. Molecular cloning of a novel type of rat cytoplasmic 17beta-hydroxysteroid dehydrogenase distinct from the type 5 isozyme.
Ishikura S; Matsumoto K; Sanai M; Horie K; Matsunaga T; Tajima K; El-Kabbani O; Hara A
J Biochem; 2006 Jun; 139(6):1053-63. PubMed ID: 16788056
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of type 2 17beta-hydroxysteroid dehydrogenase by estradiol derivatives bearing a lactone on the D-ring: structure-activity relationships.
Bydal P; Auger S; Poirier D
Steroids; 2004 May; 69(5):325-42. PubMed ID: 15219411
[TBL] [Abstract][Full Text] [Related]
34. AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer.
Rizner TL; Smuc T; Rupreht R; Sinkovec J; Penning TM
Mol Cell Endocrinol; 2006 Mar; 248(1-2):126-35. PubMed ID: 16338060
[TBL] [Abstract][Full Text] [Related]
35. Rational design of novel mutants of fungal 17beta-hydroxysteroid dehydrogenase.
Kristan K; Stojan J; Adamski J; Lanisnik Rizner T
J Biotechnol; 2007 Mar; 129(1):123-30. PubMed ID: 17196285
[TBL] [Abstract][Full Text] [Related]
36. Structure of 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase complexed with NADP+.
Bennett MJ; Schlegel BP; Jez JM; Penning TM; Lewis M
Biochemistry; 1996 Aug; 35(33):10702-11. PubMed ID: 8718859
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights.
Byrns MC; Jin Y; Penning TM
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):95-104. PubMed ID: 21087665
[TBL] [Abstract][Full Text] [Related]
38. At5g50600 encodes a member of the short-chain dehydrogenase reductase superfamily with 11beta- and 17beta-hydroxysteroid dehydrogenase activities associated with Arabidopsis thaliana seed oil bodies.
d'Andréa S; Canonge M; Beopoulos A; Jolivet P; Hartmann MA; Miquel M; Lepiniec L; Chardot T
Biochimie; 2007 Feb; 89(2):222-9. PubMed ID: 17074428
[TBL] [Abstract][Full Text] [Related]
39. Zebrafish 17beta-hydroxysteroid dehydrogenases: an evolutionary perspective.
Mindnich R; Adamski J
Mol Cell Endocrinol; 2009 Mar; 301(1-2):20-6. PubMed ID: 19111899
[TBL] [Abstract][Full Text] [Related]
40. Discovery of 2-methyl-1-{1-[(5-methyl-1H-indol-2-yl)carbonyl]piperidin-4-yl}propan-2-ol: a novel, potent and selective type 5 17β-hydroxysteroid dehydrogenase inhibitor.
Watanabe K; Kakefuda A; Yasuda M; Enjo K; Kikuchi A; Furutani T; Naritomi Y; Otsuka Y; Okada M; Ohta M
Bioorg Med Chem; 2013 Sep; 21(17):5261-70. PubMed ID: 23845281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]